MEA Cancer Vaccines Market Share

Statistics for the 2023 & 2024 MEA Cancer Vaccines market share, created by Mordor Intelligence™ Industry Reports. MEA Cancer Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of MEA Cancer Vaccines Industry

The Middle East and African cancer vaccines market is fragmented with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Some of the key players are Astellas Pharma Inc., AstraZeneca PLC, Merck & Co. Inc, GlaxoSmithKline, and Bristol-Myers Squibb.

MEA Cancer Vaccines Market Leaders

  1. AstraZeneca PLC

  2. Merck & Co. Inc.

  3. Bristol-Myers Squibb

  4. Astellas Pharma Inc.

  5. GSK plc

*Disclaimer: Major Players sorted in no particular order

MEA Cancer Vaccines Market Concentration

Middle-East and Africa Cancer Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)